…we are experienced interim managers that work in the trenches with our customers. Our independent high ethical standards, continuous search for innovative thinking combined with a inside-out implementation process is at the base of our success ! …
....we push your business beyond its current boundaries.
We tailor services with the main goal being the management of change and distinguish between several type of business services. Our experience is in both old and new economy segments. To receive a short presentation on Makwa please write us a few words: email@example.com.
Poland is now symbol of innovation and PFR Ventures – operates fund of funds, offering financing for innovative SMEs. They are looking for GP teams that will be able to rightly manage technology investments and raise funds to match their stake into the venture. David is involved in this type of venture and fundraising with an excellent team of partners. See attached 1 pager OFFTON Sp. z o.o.
Poland is growing faster then other EU countries and there is good base to build a winning life science cluster. ±€5 bil in pharma/y, ±€1bil in medical devices/y, 8000 local life science companies, about 1000 Hospitals and 20k clinics or 6H beds /000 (2x than the USA and 1.5x then CH) is a good start. Bioengineering MSc degrees are issued in english in more than one University and this adds more skills and specialized staff in the market; however all this needs a boost as there is yet not enough concentration of interconnected businesses, free contractors, associated institutions and startup wins to evidence a clear self regeneration. Some of Poland new round of grants (±€5 bil /year in development) could help if intentionally directed to this sector and partially adapted to the special requirements life science early stage projects need to achieve commercialization.
Eliza Kruczkowska, Shimi Azaria, and David G. Vita; moderator: Roi Ben Daniel.
Here a link to one of the first bioMED event we participated.
Biotechnologia.pl – Bioforum wróciło tam, gdzie jego miejsce!
A first “nexus” with foreign direct investments (FDI) was made in Poland launching an R&D center to develop a small non-invasive ear-VNS treatment of cognitive impairment degeneration / Alzheimer’s Disease @ Home. Animal studies are conducted in Lodz. .. http://pulsinnowacji.pb.pl/4638514,20557,ojciec-start-upow-inwestuje-w-polsce
opened new Poland Ventures offices in: Natolin 15, 92-703 Łódź, Poland
Makwa is in tight business contacts with Polish and Israeli technology managers to raise funds from BSD GROWTH a self managed fund based in Gibraltar. Our role will be as a GP running for FoF tenders in Poland while (if winners) use the BSD GROWTH Fund as a support investment vehicle (LP) to choose, manage and escort the targeted companies from as early as a post proof of concept (POC) stage well through the commercialisation stage into an exit.
Yigal Erlich, Adam Broncel and David Vita @ Bioforum in Lodz 2016
David quoted to say: “For every dollar’s worth of intellectual property a foreign company brings to the country (the value of which is determined by authorities), the government provides $3 in grants. And they are really interested in Israeli technologies,” http://www.timesofisrael.com/israel-poland-ready-to-do-business-despite-past-expert/
Makwa officially represented in Israel the State of Massachusetts and Massport for many years and with the unique support of the NEICC pushed Israeli companies to invest their future on “Rd128”. “Massachusetts was the trailblazer as the first US state to open a representative office here for trade and investment promotion under the auspices of the Massachusetts Office of Trade & Investment, a cabinet position of then governor William Weld with David Vita acting is the officer’s local director. (Link to full Report) For Massachusetts the investment here paid off handsomely”.
… from receivership to the TASE in 14 month for a medical equipment company dealing in the optimization of acute kidney care and fluid management. ….and finally 2 years later the company was sold to Baxter.